How much debt does Cogent Biosciences have?

According to Cogent Biosciences's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Cogent Biosciences's total debt stands at $17.47M. This is broken down into:

• Long-term debt: $15.90M
• Short-term debt: $1.56M

The company's net debt, which accounts for cash and cash equivalents, is $-80.70M. In terms of overall financial obligations, Cogent Biosciences's total liabilities amount to $71.61M.

Debt Ratios and Metrics

To better understand Cogent Biosciences's debt position, we can look at several key ratios:

• Debt to Equity Ratio: 0.07 - this indicates the proportion of equity and debt the company uses to finance its assets.
• Debt Ratio: 5.33% - this shows the proportion of a company's assets that are financed through debt.
• Interest Coverage Ratio: 0.00 - this measures how easily a company can pay interest on its outstanding debt.
• Long-term Debt to Capitalization: 5.84% - this shows the proportion of long-term debt in the company's capital structure.
• Total Debt to Capitalization: 6.38% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Cogent Biosciences's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.